Global Hydrocephalus Shunts Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

The Hydrocephalus Shunts market covers Adjustable Valves, Monopressure Valves, etc. The typical players include Medtronic, Johnson & Johnson, Integra LifeSciences, SOPHYSA, B.BRAUN, etc.
CSF diversion devices or shunts have been used successfully and have become the primary therapy for hydrocephalus treatment for nearly 60 years.
An implanted shunt diverts CSF from the ventricles within the brain or the subarachnoid spaces around the brain and spinal cord to another body region where it will be absorbed.
Shunts typically consist of three major components:
An inflow (proximal or closer to the inflow site) catheter, which drains CSF from the ventricles or the subarachnoid space; this tube leaves the brain through a small hole in the skull and then runs for a short distance under the skin.
A valve mechanism, which regulates differential pressure or controls flow through the shunt tubing; this device is connected to the proximal catheter and lies between the skin and the skull, usually on top of the head or just behind the ear.
An outflow (distal or farther away from the inflow site) catheter, which runs under the skin and directs CSF from the valve to the abdominal (or peritoneal) cavity, heart or other suitable drainage site
Other shunt components may include reservoirs and/or chambers for CSF sampling or injecting medications or dyes, on/off devices, anti-siphon or other flow-compensating devices, or auxiliary catheters to modify performance or adapt the basic system to the patient’s specialized needs. In selected cases (such as when cysts or subarachnoid fluid collections are drained), a shunt may not contain a valve or a very low resistance valve may be used.
The major players in global Hydrocephalus Shunts market include Medtronic, Johnson & Johnson, Integra LifeSciences, etc. The top 3 players occupy about 60% shares of the global market. North America is the main market, and occupies about 50% of the global market. Adjustable Valves is the main type, with a share about 65%. Adult and Child are two applications.

Market Analysis and Insights: Global Hydrocephalus Shunts Market
In 2020, the global Hydrocephalus Shunts market size was US$ 196 million and it is expected to reach US$ 338 million by the end of 2027, with a CAGR of 8.0% during 2021-2027.
Global Hydrocephalus Shunts Scope and Market Size
Hydrocephalus Shunts market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Hydrocephalus Shunts market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.


Segment by Type, the Hydrocephalus Shunts market is segmented into
Adjustable Valves
Monopressure Valves

Segment by End User, the Hydrocephalus Shunts market is segmented into
Adult
Child

Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Competitive Landscape

and Hydrocephalus Shunts Market Share Analysis
Hydrocephalus Shunts market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Hydrocephalus Shunts product introduction, recent developments, Hydrocephalus Shunts sales by region, type, application and by sales channel.

The major companies include:
Medtronic
Johnson & Johnson
Integra LifeSciences
SOPHYSA Inc
Christoph Miethke
HP Bioproteses
Spiegelberg GmbH